Chinese Markets for Central Nervous System Disorder Drugs
China's demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
Central Nervous System Disorder Drugs Industry Structure
Market Size
Market Growth Drivers
Central Nervous System Disorder Drugs Sales Volume
Major Producer Facility Locations
Major Producers’ Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
Central Nervous System Disorder Disease Overview
Central Nervous System Disorder Drugs Market Overview
Central Nervous System Disorder Drugs Market Overview by Classification
Antianxiety Drugs
Antidepressants
Antipsychotics
Anticonvulsants
Alzheimer's Disease Drugs
ADHD Drugs
Parkinson's Disease Drugs
Other Drugs
Central Nervous System Disorder Drugs Import and Export by Classification
Market Overview by Drug’s Active Principle
Market Overview by Producers
Pricing Trend
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
Central Nervous System Disorder Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
VI. MARKETING STRATEGIES
China Market Entry Overview
China’s Distribution System
Central Nervous System Disorder Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise
VII. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCER DIRECTORY
Profiles of Central Nervous System Disorder Drugs Producers
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
Top 10 Central Nervous System Disorder Drugs Sales Volume and Market Share in 2008
Central Nervous System Disorder Drugs Sales Volume
Major Producer Facility Location
Major Central Nervous System Disorder Drugs Producer Sales Volume
Major Foreign Investment in China
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
Central Nervous System Disorder Drugs Sales Volume by Classification
Central Nervous System Disorder Drugs Import by Drugs Classification
Central Nervous System Disorder Drugs Export by Drugs Classification
Top 10 Central Nervous System Disorder Drugs Sales Volume and Their Market Share in 2008
Central Nervous System Disorder Drugs Major Producer, Sales Volume, and Market Share in 2008
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
Central Nervous System Disorder Drugs Sales Volume
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
Central Nervous System Disorder Drugs Sales Volume
Central Nervous System Disorder Drugs Market Share by Drugs Classification in 2008
Top 10 Central Nervous System Disorder Drugs Market Share in 2008
Central Nervous System Disorder Drugs Sales Volume
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
Central Nervous System Disorder Drugs Sales Volume
Central Nervous System Disorder Drugs Sales Volume by Classification
Central Nervous System Disorder Drugs Import
Central Nervous System Disorder Drugs Export
Central Nervous System Disorder Drugs Market Share by Classification in 2008
Antianxiety Drugs Sales Volume and Market Share
Antidepressants Sales Volume and Market Share
Antipsychotic Sales Volume and Market Share
Anticonvulsants Sales Volume and Market Share
Alzheimer's Disease Drugs Sales Volume and Market Share
ADHD Drugs Sales Volume and Market Share
Parkinson's Disease Drugs Sales Volume and Market Share
Other Central Nervous System Disorder Drugs Sales Volume and Market Share
Central Nervous System Disorder Drugs Import by Drugs Classification in 2008
Antianxiety Drugs Import Volume and Market Share
Antidepressants Import Volume and Market Share
Antipsychotics Import Volume and Market Share
Anticonvulsants Import Volume and Market Share
Alzheimer's Disease Drugs Import Volume and Market Share
ADHD Drugs Import Volume and Market Share
Parkinson's Disease Drugs Import Volume and Market Share
Other Central Nervous System Disorder Drugs Import Volume and Market Share
Central Nervous System Disorder Drugs Export Volume by Drugs Classification in 2008
Antianxiety Drugs Export Volume and Market Share
Antidepressants Drugs Export Volume and Market Share
Antipsychotics Export Volume and Market Share
Anticonvulsants Export Volume and Market Share
Alzheimer's Disease Drugs Export Volume and Market Share
ADHD Drugs Export Volume and Market Share
Parkinson's Disease Drugs Export Volume and Market Share
Other Central Nervous System Disorder Drugs Export Volume and Market Share
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
Central Nervous System Disorder Drugs Sales Volume
VI. MARKETING STRATEGIES
China’s Distribution Channel
IBISWORLD INDUSTRY RISK RATINGS REPORTThis is the replacement for IBISWorld's October 2009 edition of Youth Programs & Miscellaneous Care Facilities in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated ...
Industries : Manage Care
The U.S Offices of Chiropractors Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and 2011 forecast estimates on the size of the industry (sales, establishments, employment) for the 47 ...
Industries : Manage Care
NRT smoking cessation aids has experienced slowing value sales over the review period, to reach virtual stagnation in 2009. Notwithstanding the fact that lifestyles are becoming healthier, the smoking ban approved in February 2009 and the too high prices of smoking cessation aids, which discourage people ...
Industries : Manage Care
Starting in late 2007, there was a lice epidemic affecting a large number of children across the country. Consequently, demand for antiparasitics/lice (head and body) treatments significantly increased in the period 2007-2009. These parasites go through a cycle that peaks about every 15 years. Educational ...
Industries : Skin Care Products, Manage Care
The proportion of adults (18 years old and over) who smoke in Mexico grew slightly from 21% in 2003 to over 22% in 2007. The total number of daily and occasional (non-daily) smokers in the country reached almost 16 million, making Mexico the second largest market for tobacco in Latin America after Brazil. ...
Industries : Manage Care
Kalorama Information publishes its third edition of this detailed report on the long term care industry at a time of growth but also change and concern for the long term care industry. The economy has challenged the business strategies of key players, while the recent healthcare legislation introduces ...
Industries : Manage Care
This is the replacement for IBISWorld's June 2010 edition of Ambulance Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Ambulance Services in Australia industry. Industry ...
Industries : Manage Care
This is the replacement for IBISWorld's April 2010 edition of Emergency Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Emergency Services in Australia industry. Industry ...
Industries : Manage Care
The key question facing home care companies is how best to pursue expansion in an industry contrasted by two different types of markets. On the one hand lies the lure of high-growth but more underdeveloped emerging markets, and on the other the sizeable but more sophisticated developed markets. This ...
Industries : Manage Care
Medicated skin care was characterised by differing performances across the various segments. The traditional categories of topical germicidals/antiseptics, topical antifungals and antipruritics continued to record low growth in 2009, mainly based on higher prices. The emerging categories of acne treatments, ...
Industries : Skin Care Products, Manage Care
Related reports
24/7 Customer Service
Contact Shadi now !
Related industries
reportlinker.com © Copyright 2010. All rights reserved
